| P50 | author | Marcel R.M. van den Brink | Q17198821 |
| P2093 | author name string | Simon Heidegger | |
| | Hendrik Poeck | |
| | Tobias Haas | |
| P2860 | cites work | Hematopoietic stem cell transplantation: a global perspective | Q24624697 |
| | Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation | Q24626051 |
| | Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease | Q24626202 |
| | NOD-Like Receptors: Master Regulators of Inflammation and Cancer | Q26865199 |
| | Recognition of cytosolic DNA by cGAS and other STING-dependent sensors | Q27000358 |
| | Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission | Q33760933 |
| | Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation | Q33839876 |
| | Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia | Q33857573 |
| | The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation | Q33898254 |
| | Advances in graft-versus-host disease biology and therapy | Q34031916 |
| | Signalling C-type lectins in antimicrobial immunity | Q34916633 |
| | Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity | Q35691842 |
| | Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). | Q35849064 |
| | LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation | Q36028584 |
| | Acute graft versus host disease | Q36059671 |
| | Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncology. | Q36132972 |
| | Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt | Q36139724 |
| | Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell t | Q36212392 |
| | An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues | Q36228795 |
| | Sensing and reacting to microbes through the inflammasomes | Q36253171 |
| | Graft-versus-host disease | Q36793622 |
| | Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies | Q36819337 |
| | TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection | Q36941127 |
| | The Nlrp3 inflammasome regulates acute graft-versus-host disease | Q37194967 |
| | NOD2 regulates hematopoietic cell function during graft-versus-host disease | Q37377427 |
| | Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality | Q37460355 |
| | TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Q37729354 |
| | IL-22, not simply a Th17 cytokine | Q38081171 |
| | Interactions between Nod-Like Receptors and Intestinal Bacteria | Q38175027 |
| | Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5 | Q38237638 |
| | Role of Bacterial Microflora in Development of Intestinal Lesions From Graft-Versus-Host Reaction | Q39137615 |
| | Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9. | Q39878275 |
| | Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation | Q40516766 |
| | Graft-versus-leukemia reactions after bone marrow transplantation | Q41198977 |
| | The role of bacteria and pattern recognition receptors in GVHD | Q41218452 |
| | Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression | Q41826765 |
| | Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. | Q42794018 |
| | MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease | Q42966829 |
| | Role of the mycobiome in human acute graft-versus-host disease | Q44211125 |
| | Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. | Q44848328 |
| | The history of Toll-like receptors - redefining innate immunity. | Q46240771 |
| | NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation | Q46588677 |
| | Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen. | Q47943611 |
| | Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells | Q50332623 |
| | Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. | Q51169431 |
| | NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. | Q51819756 |
| | P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. | Q53571198 |
| | Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. | Q54620738 |
| | Anti-endotoxin antibody for prevention of acute GVHD | Q54689661 |
| | Type I-IFNs control GVHD and GVL responses after transplantation | Q57252624 |
| | Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation | Q62658643 |
| | Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation | Q62658651 |
| | Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation | Q67919340 |
| | Observations on the role of endotoxin in graft-versus-host disease | Q68150323 |
| | Antibody titres to a rough-mutant strain of Escherichia coli in patients undergoing allogeneic bone-marrow transplantation. Evidence of a protective effect against graft-versus-host disease | Q69891899 |
| | Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora | Q70043938 |
| | Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment | Q70239474 |
| | A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease | Q71588928 |
| | Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation | Q74444949 |
| | Probiotic effects on experimental graft-versus-host disease: let them eat yogurt | Q76319360 |
| | Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation | Q78410438 |
| | Critical role of TLR9 in acute graft-versus-host disease | Q79675206 |
| | No impact of NOD2/CARD15 on outcome after SCT | Q80813551 |
| | Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 |
| | Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes | Q86518787 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 337 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation | |
| P478 | volume | 5 | |